
ThirdAge
<img alt="" height="1" width="1" />
Parkinson's Drug Doesn't Slow Disease Progress, FDA Staff Says
MedPage Today
WASHINGTON -- Azilect (rasagiline), which is already approved to treat symptoms of Parkinson's disease, does not appear effective at slowing progression of the neurodegenerative disease, ...
FDA questions Teva drug's impact on Parkinson'sBusinessWeek
FDA reviewers unconvinced on Teva Parkinson's drugReuters
FDA questions Teva drug's impact on Parkinson'sForbes
Fox Business -ThirdAge -FierceBiotech
all 25 news articles »
More...